After presenting its plan earlier this month to restructure itself to conserve cash and updating investors on its pipeline projects this week, Momenta Pharmaceuticals(NASDAQ:MNTA) shares dropped 11.3% on Thursday and 13.5% on Friday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,